Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
NetEase ADR | NTES | Jun 27, 2024 | 96.06 | -0.70 |
Netflix | NFLX | Jun 27, 2024 | 684.34 | +0.98 |
NETGEAR | NTGR | Jun 27, 2024 | 14.73 | -0.81 |
Netherlands Invstbl Mkt Idx MSCI Ishares | EWN | Jun 27, 2024 | 50.35 | +0.32 |
NetScout Systems | NTCT | Jun 27, 2024 | 18.47 | +2.04 |
NETSOL Technologies | NTWK | Jun 27, 2024 | 2.56 | +0.39 |
Netstreit | NTST | Jun 27, 2024 | 16.15 | -1.82 |
Network-1 Technologies | NTIP | Jun 27, 2024 | 1.60 | 0.00 |
Neuberger Berman | NML | Jun 27, 2024 | 8.03 | +2.42 |
Neuberger Berman High Yield Strategies Fund | NHS | Jun 27, 2024 | 7.86 | -0.13 |
Neuberger Berman Municipal Fund | NBH | Jun 27, 2024 | 10.66 | +0.19 |
Neuberger Berman Next Generation Connectivity Fund | NBXG | Jun 27, 2024 | 12.87 | +0.86 |
Neuberger Berman Real Estate Securities Income Fund | NRO | Jun 27, 2024 | 3.32 | +1.16 |
NeueHealth | NEUE | Jun 27, 2024 | 5.20 | -0.57 |
Neumora Therapeutics | NMRA | Jun 27, 2024 | 9.20 | +6.98 |
Neuraxis | NRXS | Jun 27, 2024 | 2.66 | +5.56 |
Neurobo Pharmaceuticals | NRBO | Jun 27, 2024 | 4.80 | -0.62 |
Neurocrine Biosciences | NBIX | Jun 27, 2024 | 134.31 | -1.12 |
Neurogene | NGNE | Jun 27, 2024 | 34.82 | +8.78 |
NeuroMetrix | NURO | Jun 27, 2024 | 3.71 | +0.14 |
Neuronetics | STIM | Jun 27, 2024 | 1.82 | +5.20 |
NeuroOne | NMTC | Jun 27, 2024 | 0.74 | +10.07 |
Neuropace | NPCE | Jun 27, 2024 | 7.00 | +2.19 |
NeuroSense Therapeutics | NRSN | Jun 27, 2024 | 1.02 | +19.77 |
Nevro | NVRO | Jun 27, 2024 | 8.36 | -1.99 |
New America High Income Fund | HYB | Jun 27, 2024 | 7.28 | +0.28 |
New Concept Energy | GBR | Jun 27, 2024 | 1.59 | -1.85 |
New England Realty Associates LP Unit A | NEN | Jun 27, 2024 | 70.58 | 0.00 |
New Fortress Energy A | NFE | Jun 27, 2024 | 21.11 | +0.62 |
New Found Gold | NFGC | Jun 27, 2024 | 2.89 | -1.03 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.